Keikawus Arastéh

Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia

Adriano Lazzarin, Bonaventura Clotet, David A. Cooper et al. · New England Journal of Medicine · 2003 · 653 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection

Chloe Orkin, Keikawus Arastéh, Miguel Górgolas Hernández-Mora et al. · New England Journal of Medicine · 2020 · 464 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group.

Sherry H. Stewart, H Jablonowski, F. D. Goebel et al. · Journal of Clinical Oncology · 1998 · 359 citations

Medicine, Oncology, Pharmacology +9

Durable Efficacy of Enfuvirtide Over 48 Weeks in Heavily Treatment-Experienced HIV-1-Infected Patients in the T-20 Versus Optimized Background Regimen Only 1 and 2 Clinical Trials

Mark Nelson, Keikawus Arastéh, Bonaventura Clotet et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2005 · 151 citations

Pharmacy, Internal Medicine, Pharmacotherapy +17

Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials

Giuliano Rizzardini, Edgar T. Overton, Chloe Orkin et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2020 · 149 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17